Global Neurovascular Devices Market Forecast to 2027
The Neurovascular
Devices Market is forecasted to grow from USD 2.12 Billion in
2018 to USD 3.35 Billion by 2026, at a CAGR of 5.6%, during the forecast
period. The market is primarily driven by the growing target population for
patients, favorable medical reimbursements, expansion of healthcare
infrastructure across emerging markets, and increased market demand for
effective neurovascular devices. Neurovascular therapy technological
developments, such as the development of GORE TIGRIS by W L Gore and Medtronic
distal filter embolic protection device SpiderFX, are expected to serve as a
high impact rendering driver. It is expected that inclination for minimally
invasive surgery in brain aneurysm and stroke treatments will be the key factor
that will increase market growth.
The
report also covers the impact of the COVID-19 pandemic on the Neurovascular
Devices market and major segments. The pandemic has affected every industry
vertical either positively or negatively. The report discusses in detail the
changes in the demands and trends and the major challenges of the market
created due to the pandemic. The report also offers a thorough current and
future analysis of the impact of the COVID-19 pandemic on the overall growth of
the market.
To get a sample PDF copy of the report,
visit @ https://www.reportsanddata.com/sample-enquiry-form/1348
The
report presents a panoramic view of the competitive landscape of the Neurovascular
Devices market, covering details about the key manufacturers and companies,
price analysis, revenue estimation, gross profit margins, business expansion
plans, and other vital details that offers the readers deep insights into each
company operating in the industry. The report also focuses on strategic
alliances in the Neurovascular Devices market, such as mergers and
acquisitions, joint ventures, product launches, brand promotions,
collaborations, licensing agreements, partnerships, corporate and government
deals, and others.
Top Players Analyzed in the Report are:
W.
L. Gore & Associates, Inc. (US), Terumo Corp. (Japan), Abbott Laboratories
(US), Merit Medical Systems, Inc. (US), Medtronic Plc (Ireland), Penumbra, Inc.
(US), Stryker Corp. (US), Johnson & Johnson (US), MicroPort Scientific
Corp. (China) and others.
Product Type Segmentation:
Cerebral
Embolization and Aneurysm Coiling
Cerebral
Angioplasty and Stenting Systems
Neurothrombectomy
Support
Application Segmentation:
Cerebral
Artery Stenosis
Stroke
Cerebral
Aneurysm
Others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1348
Regional Analysis Covers:
North
America (U.S., Canada)
Europe
(U.K., Italy, Germany, France, Rest of EU)
Asia
Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin
America (Chile, Brazil, Argentina, Rest of Latin America)
Middle
East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
For
a comprehensive value chain analysis, the report covers the downstream and
upstream essentials of the Neurovascular Devices market. It also pays special
focus on the growth process, macro- and micro-economic factors, raw material
sources analysis, and other technical data. The report further segments the
market on the basis of types, applications, and regions and offers insights
into the segments that have the highest penetration and profit margin, along
with recent developments based on geographies.
Benefits of Global Neurovascular Devices Market
Report:
·
Comprehensive analysis of
the changing market dynamics
·
A futuristic outlook on
different factors influencing the market
·
An 8-year forecast of the
market growth and expected revenue growth
·
Ease of understanding of
the market, key segments, and their future growth
·
In-depth analysis of the
competitive landscape to give an advantageous edge for the companies
·
Extensive insight into
the market with in-depth analysis of the segmentation
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/neurovascular-devices-market
Thank
you for reading our report. For further queries or inquiries about
customization, kindly connect with us to know more. Our team will ensure the
report is tailored according to your needs.
Contact
Us:
John
Watson
Head
of Business Development
Direct
Line: +1-212-710-1370
E-mail:
sales@reportsanddata.com